K Pharma,Inc. (4896.T)

JPY 756.0

(-1.82%)

Annual Cash Flows

(In JPY)
Breakdown 2023 2022 2021
Operating Cash Flow 454.42 Million -363.48 Million -196.32 Million
Net Income 301.07 Million -390.52 Million -229.11 Million
Depreciation & Amortization - - 6.8 Million
Deferred income taxes - - -
Stock-based compensation - - -
Change in working capital 90.2 Million -9.18 Million 16.46 Million
Other non-cash items 21.92 Million 5.5 Million 1.4 Million
Investing Cash Flow -11.09 Million -32.73 Million -250 Thousand
Investments in PPE -9.8 Million -29.95 Million -
Acquisitions - - -
Investment purchases - - -
Sales/Maturities of investments - - -
Other Investing Activities -1.29 Million -2.77 Million -250 Thousand
Financing Cash Flow 1.48 Billion 1.54 Billion 368.2 Million
Debt repayment - - -30 Million
Dividends payments - - -
Common Stock Repurchased - - -
Common Stock Issuance 1.49 Billion 1.54 Billion 398.2 Million
Other Financing Activities -10.09 Million -90 Thousand -
Accounts receivables - - -
Accounts payables 1.75 Million 7.46 Million -119 Thousand
Inventory -598 Thousand -313 Thousand -18 Thousand
Other working capital 89.14 Million -16.24 Million 16.6 Million
Cash at beginning of period 1.33 Billion 188.78 Million 17.15 Million
Cash at end of period 3.26 Billion 1.33 Billion 188.78 Million
Capital Expenditure -9.8 Million -29.95 Million -
Effect of forex changes on cash - - -
Net cash flow / Change in cash 1.92 Billion 1.14 Billion 171.63 Million
Free Cash Flow 444.62 Million -393.44 Million -196.32 Million

Cash Flow Charts